Role of Metabolism‐Coupled Protein Modification in Diabetic Cardiomyopathy
Journal of Diabetes · 2026-11 · 18 (11)
DOI: 10.1111/1753-0407.70299 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Diabetes, online erschienen am 15.11.2026. Verfasst von Qian Lei und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electro…. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Protein Processing, Post-Translational, Myocardium, Energy Metabolism. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Clinical Research Program of the National Health Commission of China.
Abstract (Originalsprache)
Diabetic cardiomyopathy (DCM) is a diabetes‐specific myocardial disorder, characterized by structural and functional abnormalities of the heart independent of coronary artery disease, hypertension, or valvular pathology. Metabolic abnormalities are now understood to play pivotal roles in DCM pathogenesis. Chronic hyperglycemia and insulin resistance disrupt cardiac energy metabolism, shifting myocardial substrate utilization from glucose to fatty acids. These metabolic disorders lead to imbalances in intracellular metabolite abundance, which, in turn, induce abnormalities in various biochemical reactions involving these metabolites, including post‐translational modifications (PTMs) of proteins. The strong correlation between metabolism and protein PTMs has led to the concept of metabolically coupled protein modifications (MCPMs). In this narrative review, we define strict MCPMs as PTMs that directly use metabolites as substrates, and we also discuss metabolism‐related PTMs such as phosphorylation and ROS/RNS‐mediated modifications. We summarize reported roles of MCPMs in DCM, distinguish evidence levels, and outline major issues for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Qian Lei, Juanjuan Lyu
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Clinical Research Program of the National Health Commission of China
Zitieren
APA
Lei, Q., & Lyu, J. (2026). Role of Metabolism‐Coupled Protein Modification in Diabetic Cardiomyopathy. Journal of Diabetes, 18(11). https://doi.org/10.1111/1753-0407.70299
Vancouver
Lei Q, Lyu J. Role of Metabolism‐Coupled Protein Modification in Diabetic Cardiomyopathy. Journal of Diabetes. 2026;18(11). doi:10.1111/1753-0407.70299
BibTeX
@article{Lei2026,
author = {Lei, Qian and Lyu, Juanjuan},
title = {Role of Metabolism‐Coupled Protein Modification in Diabetic Cardiomyopathy},
journal = {Journal of Diabetes},
year = {2026},
volume = {18},
number = {11},
doi = {10.1111/1753-0407.70299}
}
EUVIMED